Abstract
Steep price hikes following the debranding of off-patent medicines are becoming increasingly common in the UK, adding hundreds of millions to the NHS drugs bill. But can anything be done to prevent this?
| Original language | English |
|---|---|
| Pages (from-to) | 44-46 |
| Number of pages | 3 |
| Journal | Prescriber |
| Volume | 28 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 30 Apr 2017 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver